ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Lists Initiatives, Web Links For Info, About Research On Prostate Cancer

December 11, 1998

ASTRO Issues Statement On APBI For Breast Cancer

August 28, 2009

Donald Coffey Is President-Elect Of NCCR; Coalition Elects Five New Board.

January 28, 2000

Clinical Center Director Plans Revitalization of Research Training

December 9, 1994

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997

Capitol Hill: Advocates Lobby Congress To Close Medicare Loophole For Colonoscopy Coverage

July 18, 2014